Spirocyclic pyridoazepine analogues of galanthamine: Synthesis, modelling studies and evaluation as inhibitors of acetylcholinesterase

European Journal of Organic Chemistry

Volumn , Issue 15, 2008, Pages 2571-2581

  Vanlaer, Sofie ^a   De Borggraeve, Wim M ^a   Voet, Arnout ^a   Gielens, Constant ^a   De Maeyer, Marc ^a   Compernolle, Frans ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Docking simulations; Enzymes; Heck reaction; Nitrogen heterocycles; Nucleophilic substitution; Spiro compounds

Indexed keywords

EID: 53849096698     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200800062     Document Type: Article

References (26)

1. H. Sugimoto, H. Ogura, Y. Arai, Y. Iimura, Y. Yamanishi, Jpn. J. Pharmacol. 2002, 89, 7-20.
2. P. Bar-On, C. B. Millard, M. Harel, H. Dvir, A. Enz, J. L. Sussman, I. Silman, Biochemistry 2002, 41, 3555-3564.
3. a) H. A. M. Mucke, Drugs Today 1997, 33, 251-257;
4. b) M. Weinstock, CNS Drugs 1999, 12, 307-323;
5. c) M. Rainer, Drugs Today 1997, 33, 273-279;
6. d) H. M. Greenblath, G. Kryger, T. Lewis, I. Silman, J. L. Sussman, FEBS Lett. 1999, 463, 321-326.
7. M. Colombres, J. P. Sagal, N. C. Inestrosa, Curr. Pharm. Des. 2004, 10, 3121-3130.
8. a) B. M. Trost, F. D. Toste, J. Am. Chem. Soc. 2000, 122, 11262-11263;
9. b) B. M. Trost, W. Tang, F. D. Toste, J. Am. Chem. Soc. 2005, 127, 14785-14803;
10. c) J. Marco-Contelles, M. Carreiras, C. Rodriguez, M. Villarroya, A. G. Garcia, Chem. Rev. 2006, 106, 116-133;
11. d) S. E. Gibson, R. J. Middleton, Contemp. Org. Synth. 1996, 3, 447-471.
12. a) A. H. Lewin, J. Szewczyk, J. W. Wilson, F. I. Carroll, Tetrahedron 2005, 61, 7144-7152;
13. b) S. Y. Han, J. E. Sweeney, E. S. Bachean, E. J. Schweiger, G. Porloni, J. T. Coyle, B. M. Davis, M. M. Jouillé, Eur. J. Med. Chem. 1992, 27, 673-687.
14. a) P. Liang, J. Liu, L. Hsin, C. Cheng, Tetrahedron 2004, 60, 11655-11660;
15. b) P. Liang, L. Hsin, S. Pong, C. Hsu, C. Cheng, J. Chin. Chem. Soc. 2003, 50, 449-456.
16. L. Meerpoel, G. J. Hoornaert, Synthesis 1990, 905-908.
17. a) L. Meerpoel, G. Deroover, K. J. Van Aken, G. Lux, G. J. Hoornaert, Synthesis 1991, 765-768;
18. b) K. J. Van Aken, G. M. Lux, G. G. Deroover, L. Meerpoel, G. J. Hoornaert, Tetrahedron 1994, 50, 5211-5224.
19. a) J. S. Hon, S. W. Lin, Y. W. Chen, Synth. Commun. 1993, 23, 1543;
20. b) M. J. Aurell, L. Ceita, R. Mestres, A. Tortajada, Tetrahedron 1997, 53, 10883-10898.
21. S. Wang, Y. Lee, S. Hsu, H. Chang, W. Yin, L. Chang, S. Chou, Bioorg. Med. Chem. 2007, 15, 735-748.
22. G. L. Ellman, K. D. Courtney, V. Andres, R. M. Featherstone, Biochem. Pharmacol. 1961, 7, 88-95.
23. GAL is measured as (-)-GAL. Target compounds 3a-d and 4b are measured as a mixture of enantiomers.
24. MOE (The Molecular Operating Environment), version 2005.06. Software available from Chemical Computing Group Inc., 1010 Sherbrooke Street West, Suite 910, Montreal, Canada H3A 2R7. http://www.chemcomp.com.
25. C. Bartolucci, E. Perola, C. Pilger, G. Fels, D. Lamba, Proteins 2001, 42, 182-191.
26. H. Edelsbrunner, Weighted Alpha Shapes, Department of Computer Science, University of Illinois at Urbana-Champaign, Urbana, Illinois 61810.